BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Kirova YM, Chargari C. Applications of new irradiation modalities in patients with lymphoma: Promises and uncertainties. World J Radiol 2011; 3(3): 66-69 [PMID: 21512653 DOI: 10.4329/wjr.v3.i3.66]
URL: https://www.wjgnet.com/1949-8470/full/v3/i3/66.htm
Number Citing Articles
1
Pierre Loap, Alfredo Mirandola, Ludovic De Marzi, Remi Dendale, Alberto Iannalfi, Viviana Vitolo, Amelia Barcellini, Andrea Riccardo Filippi, Barbara Alicja Jereczek-Fossa, Youlia Kirova, Ester Orlandi. Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to EvidenceCancers 2021; 13(15): 3746 doi: 10.3390/cancers13153746
2
Ahmad K. Darwazah. Surgical Management of Coronary Artery Disease Associated with MalignancyJournal of Cardiac Surgery 2012; 27(5): 581 doi: 10.1111/j.1540-8191.2012.01514.x
3
A. Servy, N. Kramkimel, N. Franck, S. Park, Y.M. Kirova. Helical tomotherapy in oncodermatology: Case report of circumferential cutaneous lymphoma treated by this optimized radiotherapyCancer/Radiothérapie 2014; 18(2): 136 doi: 10.1016/j.canrad.2013.10.011
4
Vitaliana De Sanctis, Chiara Bolzan, Marco D’Arienzo, Stefano Bracci, Alessandro Fanelli, Maria Christina Cox, Maurizio Valeriani, Mattia F Osti, Giuseppe Minniti, Laura Chiacchiararelli, Riccardo Maurizi Enrici. Intensity modulated radiotherapy in early stage Hodgkin lymphoma patients: Is it better than three dimensional conformal radiotherapy?Radiation Oncology 2012; 7(1) doi: 10.1186/1748-717X-7-129
5
P. Loap, F. Goudjil, R. Dendale, Y. Kirova. Clinical and technical considerations for mediastinal Hodgkin lymphoma protontherapy based on a single-center early experienceCancer/Radiothérapie 2021; 25(8): 779 doi: 10.1016/j.canrad.2021.06.016